AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 118 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $103,000 | -44.6% | 10,830 | -13.4% | 0.03% | -44.3% |
Q4 2017 | $186,000 | -65.9% | 12,500 | -55.0% | 0.06% | -66.3% |
Q3 2017 | $546,000 | -31.0% | 27,770 | -49.6% | 0.18% | -19.9% |
Q2 2017 | $791,000 | +32.9% | 55,075 | -14.8% | 0.23% | +59.2% |
Q1 2017 | $595,000 | – | 64,655 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |